Garrett Hamontree, MBA
Principal and Chief Financial Officer
California, United States
11 investmentsSign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (11)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Orasis Pharmaceuticals | — | — | — | — |
| 2 | RxSight | — | — | — | — |
| 3 | Tarsus Pharmaceuticals | — | — | — | — |
| 4 | Surface Pharmaceuticals | — | — | — | — |
| 5 | Tear Film Innovations | — | — | — | — |
| 6 | Re-Vana Therapeutics | — | — | — | — |
| 7 | Mynosys Cellular Devices | — | — | — | — |
| 8 | Iantech | — | — | — | — |
| 9 | CorneaGen | — | — | — | — |
| 10 | Equinox | — | — | — | — |
| 11 | TearClear | — | — | — | — |
Showing 1–11 of 11
Access Full Contact Information
Get Garrett Hamontree, MBA's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required